TWD
BPMC

True Wealth Design’s Blueprint Medicines BPMC Stock Holding History

True Wealth Design’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-184
Closed -$23.6K – 2735
2025
Q2 		$23.6K Buy
184
+35
+23% +$3.63K 0.01% 349
2025
Q1 		$13.2K Sell
149
-1
-0.7% -$98 0.01% 408
2024
Q4 		$13.1K Buy
150
+15
+11% +$1.37K 0.01% 381
2024
Q3 		$12.5K Buy
+135
New +$13.4K ﹤0.01% 390

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

True Wealth Design's BPMC Position: Q3 2025 in Review

True Wealth Design sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 184 shares — an estimated $23.6K sold.

True Wealth Design first reported a position in BPMC in Q3 2024 and held it in 4 quarters. The position peaked at $23.6K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • True Wealth Design reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • True Wealth Design sold 184 Blueprint Medicines shares in Q3 2025, an estimated $23.6K.
  • True Wealth Design first reported a position in Blueprint Medicines in Q3 2024 and held it in 4 quarters.
  • True Wealth Design's Blueprint Medicines position peaked at $23.6K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on True Wealth Design's 13F filing for Q3 2025, filed 21 Oct 2025.